Abstract
Treatment of heart failure should include correction of the underlying cause. These causes include large left to right shunts, obstructive lesions, arrhythmias, primary myocardial disease etc. The main pharmacological therapy includes inotropic agents, vasodilators and diuretics. Inotropic agents increase myocardial contractility and include digoxin, intravenous dopamine, dobutamine and isoproterenol. Vasodilators improve cardiac pump performance by decreasing the vascular resistance and/or increasing the venous capacitance. Commonly used vasodilator agents include angiotensin converting enzyme inhibitors (captopril, enalapril etc.), hydralazine, prazosin hydrochloride etc. Diuretics inhibit salt and water reabsorption promoting their excretion. Furosemide, thiazide diuretics, aldactone, are commonly used diuretics. Electrolyte and acid-base imbalance can occur on chronic diuretic therapy. Cardiac transplantation is considered for patients where all medical management has failed.
Similar content being viewed by others
References
Katz AM. Changing strategies in the management of heart failure.J Am Coll Cardiol, 1989; 13: 513–523.
Parmely WW. Pathophysiology and current therapy of congestive heart failure.J Am Coll Cardiol, 1989; 13: 771–785.
Cohn JN. The management of chronic heart failure.N Engl J Med, 1996; 335: 490–498.
Heart Disease in Infants, Children and Adolsecents. 5th Edition, Baltimore: Williams and Wilkins, 1995. Talner NS,Heart Failure, 1746–1773, Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP (eds).
The Science and Practice of Pediatric Cardiology, Philadelphia: Lea and Febiger, 1990. Dreyer WJ, Congestive Heart Failure, 2007–2023. Garson Jr. A, Bricker, JT, McNamara DG (eds).
Artman M, Parrish MD, Graham TP Jr. Congestive heart failure in childhood and adolescence: recognition and management.Am Heart J 1983; 105: 471–480.
Artman M, Graham TP Jr. Guidelines for vasodilator therapy of congestive heart failure in infants and children.Am Heart J, 1987; 113: 994–1005.
Parmley WW. Neuroendocrine changes in heart failure and their clinical relevance.Clin Cardiol 1995; 18: 440–445.
Opie LH. Fundamental role of angiotensin converting enzyme inhibitors in the management of congestive heart failure.Am J Cardiol 1995; 75: 3F-6F.
Waagstein F, Bristow MR, Swedberg K,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy.Lancet 1993; 342: 1441–1446.
Packer M, Bristow MR, Cohn JN,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.N Engl J Med 1996; 334: 1349–1355.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, Sc. Recent advances in the treatment of congestive heart failure. Indian J Pediatr 65, 13–20 (1998). https://doi.org/10.1007/BF02849687
Issue Date:
DOI: https://doi.org/10.1007/BF02849687